The copper transporter CTR1 regulates cisplatin uptake in Saccharomyces cerevisiae

Molecular Pharmacology

Volumn 62, Issue 5, 2002, Pages 1154-1159

  Lin, Xinjian ^a   Okuda, Tsuyoshi ^a   Holzer, Alison ^a   Howell, Stephen B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMINEDICHLORO(2 METHYLPYRIDINE)PLATINUM; CARBOPLATIN; CISPLATIN; CISPLATIN DERIVATIVE; COPPER; GENE PRODUCT; OXALIPLATIN; PROTEIN CTR1; UNCLASSIFIED DRUG;

ARTICLE; CELL LEVEL; CELL TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG RESISTANCE; DRUG UPTAKE; GENE CONTROL; GENE DELETION; GENE FUNCTION; ION TRANSPORT; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; TIME; WILD TYPE;

ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT; CATION TRANSPORT PROTEINS; CELL DIVISION; CISPLATIN; COPPER; DRUG INTERACTIONS; MEMBRANE PROTEINS; PLATINUM; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS;

EID: 0036840625     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.62.5.1154     Document Type: Article

References (40)

1. Andrews PA and Albright KD (1991) Role of membrane ion transport in cisplatin accumulation, in Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy (Howell SB ed) pp. 151-159, Plenum Press, New York.
2. Andrews PA and Howell SB (1990) Cellular pharmacology of cisplatin: Perspectives on mechanisms of acquired resistance. Cancer Cells 2:35-43.
3. +-ATPase in the accumulation of cis-diammine-dichloroplatinum(II) in human ovarian carcinoma cells. Cancer Res 51:3677-3681.
4. Canada RG and Paltoo DN (1998) Binding of terbium and cisplatin to C13* human ovarian cancer cells using time-resolved terbium luminescence. Biochim Biophys Acta 1448:85-98.
5. Chen ZS, Mutoh M, Sumizawa T, Furukawa T, Haraguchi M, Tani A, Saijo N, Kondo T, and Akiyama S (1998) An active efflux system for heavy metals in cisplatin-resistant human KB carcinoma cells. Exp Cell Res 240:312-320.
6. Dancis A, Yuan DS, Haile D, Askwith C, Eide D, Moehle C, Kaplan J, and Klausner RD (1994) Molecular characterization of a copper transport protein in S. cerevisiae: An unexpected role for copper in iron transport. Cell 76:393-402.
7. Danks DM (1995) The Metabolic and Molecular Basis of Inherited Disease. McGrawHill, New York.
8. Djuran M and Milinkovic S (2000) HNMR investigations of the selective intramolecular migration of a platinum (II) complex from Methionine Sulfur to Imidazole N 1 in N-acetylated L-methionyl-L-histidine. Aust J Chem 53:645-649.
9. Fink D, Aebi S, and Howell SB (1998) The role of DNA mismatch repair in drug resistance. Clin Cancer Res 4:1-5.
10. Gately DP and Howell SB (1993) Cellular accumulation of the anticancer agent cisplatin: A review. Br J Cancer 67:1171-1176.
11. Haga A, Nagase H, Kito H, and Sato T (1997) Invasive properties of cadmium-resistant human fibrosarcoma HT-1080 cells. Cancer Biochem Biophys 15:275-84.
12. Johnson SW, Laub PB, Beesley JS, Ozols RF, and Hamilton TC (1997) Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell lines. Cancer Res 57:850-856.
13. Katano K, Safaei R, Kondo A, Samimi G, Holzer A, Naerdemann W and Howell SB (2002a) Pharmacogenomic abnormalities associated with acquired resistance to cisplatin (Abstract). Proc Am Assoc Cancer Res 43:1104.
14. Katano K, Safaei R, Samimi G, Holzer A, Naerdemann W, and Howell SB (2002b) Acquired resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper (Abstract). Proc Am Assoc Cancer Res 43:495.
15. Katano K, Safaei R, Samimi G, Naerdemann W, Holzer A, and Howell SB (2002c) Copper-transport P-type adenosine triphosphatase (ATP7B) modifies cisplatin resistance of carcinoma cells (Abstract). Proc Am Assoc Cancer Res 43:423.
16. Klomp LW, Lin SJ, Yuan DS, Klausner RD, Culotta VC, and Gitlin JD (1997) Identification and functional expression of HAH1, a novel human gene involved in copper homeostasis. J Biol Chem 272:9221-9226.
17. Komatsu M, Sumizawa T, Mutoh M, Chen Z-S, Terada K, Furukawa T, Yang X-L, Gao H, Miura N, Sugiyama T, et al. (2000) Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance. Cancer Res 60:1312-1316.
18. Koropatnick J and Pearson J (1990) Zinc treatment, metallothionein expression and resistance to cisplatin in mouse melanoma cells. Somat Cell Mol Genet 16:529-537.
19. Kuo YM, Zhou B, Cosco D, and Gitschier J (2001) The copper transporter CTR1 provides an essential function in mammalian embryonic development. Proc Natl Acad Sci USA 98:6836-6841.
20. Lee J, Prohaska JR, Dagenais SL, Glover TW, and Thiele DJ (2000) Isolation of a murine copper transporter gene, tissue specific expression and functional complementation of a yeast copper transport mutant. Gene 254:87-96.
21. Lee J, Prohaska JR, and Thiele DJ (2001) Essential role for mammalian copper transporter Ctr1 in copper homeostasis and embryonic development. Proc Natl Acad Sci USA 98:6842-6847.
22. Lee KB, Parker RJ, and Reed E (1995) Effect of cadmium on human ovarian cancer cells with acquired cisplatin resistance. Cancer Lett 88:57-66.
23. Naredi P, Heath DD, Enns RE, and Howell SB (1994) Cross-resistance between cisplatin and antimony in a human ovarian carcinoma cell line. Cancer Res 54:6464-6468.
24. Naredi P, Heath DD, Enns RE, and Howell SB (1995) Cross-resistance between cisplatin, antimony, potassium tartrate, and arsenite in human tumor cells. J Clin Invest 95:1193-1198.
25. Nicholson DL, Purser SM, and Maier RH (1998) Differential cytotoxicity of trace metals in cisplatin-sensitive and -resistant human ovarian cancer cells. Biometals 11:259-263.
26. Pena MM, Lee J, and Thiele DJ (1999) A delicate balance: Homeostatic control of copper uptake and distribution. J Nutr 129:1251-1260.
27. Pena MM, Puig S, and Thiele DJ (2000) Characterization of the saccharomyces cerevisiae high affinity copper transporter ctr3. J Biol Chem 275:33244-33251.
28. Perego P, Vande Weghe J, Ow DW, and Howell SB (1997) Role of determinants of cadmium sensitivity in the tolerance of Schizosaccharomyces pombe to cisplatin. Mol Pharmacol 51:12-18.
29. Perez RP, Hamilton TC, Ozols RF, and Young RC (1993) Mechanisms and modulation of resistance to chemotherapy in ovarian cancer. Cancer 71:1571-1580.
30. Raynaud FI, Boxall FE, Goddard PM, Valenti M, Jones M, Murrer BA, Abrams M, and Kelland LR (1998) cis-amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: In vivo activity, toxicology, and pharmacokinetics in mice. Clin Cancer Res 3:2063-2074.
31. Romach EH, Zhao CQ, Del Razo LM, Cebrian ME, and Waalkes MP (2000) Studies on the mechanisms of arsenic-induced self tolerance developed in liver epithelial cells through continuous low-level arsenite exposure. Toxicol Sci 54:500-8.
32. Safaei R and Howell SB (2001) Cross-resistance between cisplatin, carboplatin, copper and arsenite in human tumor cell lines (Abstract). Proc Am Assoc Cancer Res 42:424.
33. Safaei RK, K., Samimi G, Naerdemann W, Howell SB (2002) Cisplatin resistance is mediated by copper homeostasis mechanisms (Abstract). Proc Am Assoc Cancer Res 43:423.
34. Schilder RJ, Hall L, Monks A, Handel LM, Fornace AJ Jr, Ozols RF, Fojo AT, and Hamilton TC (1990) Metallothionein gene expression and resistance to cisplatin in human ovarian cancer. Int J Cancer 45:416-422.
35. Strandberg MC, Bresnick E, and Eastman A (1982) The significance of DNA cross-linking to cis-diamminedichloroplatinum(II)-induced cytotoxicity in sensitive and resistant lines of murine leukemia L1210 cells. Chem-Biol Interact 39:169-180.
36. Theophanides T and Anastassopoulou J (2002) Copper and carcinogenesis. Crit Rev Oncol Hematol 42:57-64.
37. Tobey RA and Tesmer JG (1985) Differential response of cultured human normal and tumor cells to trace element-induced resistance to the alkylating agent melphalan. Cancer Res 45:2567-2571.
38. 2+ model adducts. Am Chem Soc 38:1450-1455.
39. Zhou B and Gitschier J (1997) hCTR1: A human gene for copper uptake identified by complementation in yeast. Proc Natl Acad Sci USA 94:7481-7486.
40. Zhou H and Thiele DJ (2001) Identification of a novel high affinity copper transport complex in the fission yeast Schizosaccharomyces pombe. J Biol Chem 276:20529-20535.